688315.SHG Novogene Co. Ltd.

Healthcare Biotechnology Shanghai Stock Exchange
17.25 CNY
Close of Nov 4, 2026
11.46 23.43
Market cap
CNY 7.18B
P/E
44.2x
P/B
2.53x
ROE
4.7%
Dividend yield
0.28%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 688315.SHG undervalued?

Graham number
Price17.25
Graham value7.74
Premium122.9%

688315.SHG trades 122.9% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Novogene Co. Ltd. fundamental analysis

No fundamental analysis for Novogene Co. Ltd. yet.

Novogene Co. Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Novogene Co. Ltd.

Novogene Co., Ltd., together with its subsidiaries, provides genomic services and solutions in Mainland China, Hong Kong, Macau, Taiwan, and internationally. The company offers genomic solutions comprising human, animal, plant, and microbial whole genome sequencing, as well as human and mouse whole exome sequencing, microbial de novo sequencing, animal and plant de novo sequencing, and 16S/18S/ITS amplicon and shotgun metagenomic sequencing; transcriptomics solutions, such a…

Full company profile